- Lobbying
- Lobbying by Aralez Pharmaceuticals US, Inc. (formerly Pozen Inc.)
Lobbying Relationship
Bills mentioned
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Chris Jones | Chief of Staff/Rep. Mike Ferguson Deputy Chief of Staff/Rep. David McIntosh Communications Dir./House Govt. Reform and Oversight Subcmte Press Secretary/Rep. John Myers |
Adam Higgins | Legislative Assistant/Rep. Mike Ferguson |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Policy issues relating to market exclusivity and patent exclusivity for innovative pharmaceutical manufacturers.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act."
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee re-authorization..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate